Rapid emergence of multimarker strategies in laboratory medicine

Biomarkers

Volumn 15, Issue 4, 2010, Pages 289-296

  Gruson, D ^a   Bodovitz, S ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b BioPerspectives   (United States)

Author keywords

Algorithm; Biomarkers; Combination; Information technologies; Multiplexed diagnostics; Multivariate

Indexed keywords

ALDOSTERONE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; EPIDERMAL GROWTH FACTOR RECEPTOR; FATTY ACID BINDING PROTEIN; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTATE SPECIFIC ANTIGEN; RENIN; SCATTER FACTOR RECEPTOR; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ALGORITHM; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; AUGMENTATION INDEX; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART INFARCTION; HUMAN; HYPERTENSION; INFORMATION TECHNOLOGY; LABORATORY; LEUKOCYTE ACTIVATION; LIVER FUNCTION; MEDICAL DECISION MAKING; MEDICINE; PRIMARY HYPERALDOSTERONISM; PROTEIN PHOSPHORYLATION; PULSE WAVE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; DIAGNOSIS; DISEASE; HUMANS; MASS SPECTROMETRY; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TECHNOLOGY, MEDICAL;

EID: 77952534146     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547500903560065     Document Type: Review

References (40)

1. Amonkar SD, Bertenshaw GP, Chen TH, Bergstrom KJ, Zhao J, Seshaiah P, Yip P, Mansfield BC. (2009). Development and preliminary evaluation of a multivariate index assay for ovarian cancer. PLoS ONE 4: e4599.
2. Apple FS, Smith SW, Pearce LA, Murakami MM. (2009). Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 55:93-100.
3. Arant CB, Wessel TR, Ridker PM, Olson MB, Reis SE, Delia JB, Sharaf BL, Pauly DF, Handberg E, Zineh I, Sopko G, Kelsey S F, Noel Bairey MC, Pepine CJ. (2009). Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation. Clin Cardiol 32:244-50.
4. Boutros PC, Lau SK, Pintilie M, Liu N, Shepherd FA, Der SD, Tsao MS, Penn LZ, Jurisica I. (2009). Prognostic gene signatures for nonsmall-cell lung cancer. Proc Natl Acad Sci USA 106:2824-8.
5. Campbell DJ, Nussberger J, Stowasser M, Danser AH, Morganti A, Frandsen E, Menard J. (2009). Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 55:867-77.
6. Cronin M, Sangli C, Liu ML, Pho M, Dutta D, Nguyen A, Jeong J, Wu J, Langone KC, Watson D. (2007). Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer. Clin Chem 53:1084-91.
7. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. (2007). Cerebrospinal fluid tau/beta-amyloid (42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 64:343-9.
8. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, Van't Veer LJ, Perou CM. (2006). Concordance among gene-expressionbased predictors for breast cancer. N Engl J Med 355:560-9.
9. Glas AM, Floore A, Delahaye LJ, Witteveen AT, Pover RC, Bakx N, Lahti-Domenici JS, Bruinsma TJ, Warmoes MO, Bernards R, Wessels LF, Van't Veer LJ. (2006). Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7:278.
10. Halfon P, Munteanu M, Poynard T. (2008). FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Gastroenterol Clin Biol 32 (6 Suppl. 1):22-39.
11. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. (2006). Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5:228-34.
12. Harima Y, Ikeda K, Utsunomiya K, Shiga T, Komemushi A, Kojima H, Nomura M, Kamata M, Sawada S. (2009). Identification of genes associated with progression and metastasis of advanced cervical cancers after radiotherapy by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 75:1232-9.
13. Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT. (2008). Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 199:3-11.
14. Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jafe AS. (2007). Risk stratification for heart failure and death in an acute coronary syndrome population using infammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem 53:2112-18.
15. Le Calvez S, Tabut D, Messous D, Munteanu M, Ratziu V, Imbert-Bismut F, Poynard T. (2004). The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C. Hepatology 39:862-3.
16. Lieb W, Larson MG, Benjamin EJ, Yin X, Tofler GH, Selhub J, Jacques PF, Wang TJ, Vita JA, Levy D, Vasan RS, Mitchell G F. (2009). Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation 119:37-43.
17. Lindahl B. (2009). Multimarker approach for diagnosis of acute myocardial infarction: better answers need better questions. Clin Chem 55:9-11.
18. Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B, Winans M, Bigbee W, Siegfried J, Lokshin A, Ferris RL. (2007). Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobeadbased biomarker profiling. Cancer Epidemiol Biomarkers Prev 16:102-7.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-19.
20. McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA. (2009). Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. Am J Cardiol 103:22-8.
21. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engstrom G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler NG, Bergmann A, Pencina MJ, Wang TJ. (2009). Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302:49-57.
22. Mockel M, Danne O, Muller R, Vollert JO, Muller C, Lueders C, Stork T, Frei U, Koenig W, Dietz R, Jaffe AS. (2008). Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin Chim Acta 393:103-9.
23. Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, Gajewski W, Kurman R, Bast RC Jr, Skates SJ. (2009). A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol 112:40-6.
24. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr. (2004). Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from fve continents. J Clin Endocrinol Metab 89:1045-50.
25. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N. (2004). A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817-26.
26. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N. (2006). Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24:3726-34.
27. Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Tompson IM, Zheng Y. (2008). Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol 167:362-8
28. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Tabut D, Le Calvez S, Messous D, Tibault V, Benhamou Y, Moussalli J, Ratziu V. (2004). Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 50:1344-55.
29. Ridker PM, Buring JE, Rifai N, Cook NR. (2007). Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297:611-19.
30. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. (2008). C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 118:2243-51, 4p.
31. Roberts C, McNamee R. (2005). Assessing the reliability of ordered categorical scales using kappa-type statistics. Stat Methods Med Res 14:493-514.
32. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. (2002). Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105:1760-3.
33. Sepehri AA, Hancq J, Dutoit T, Gharehbaghi A, Kocharian A, Kiani A. (2008). Computerized screening of children congenital heart diseases. Comput Methods Programs Biomed 92:186-92.
34. Sheu CC, Chang MY, Chang HC, Tsai JR, Lin SR, Chang SJ, Hwang JJ, Huang MS, Chong IW. (2006). Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer. Oncology 70:203-11.
35. Slodkowska EA, Ross JS. (2009). MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients. Expert Rev Mol Diagn 9:417-22.
36. Sunami E, Shinozaki M, Higano CS, Wollman R, Dorff TB, Tucker SJ, Martinez SR, Singer FR, Hoon DS. (2009). Multimarker circulating DNA assay for assessing blood of prostate cancer patients. Clin Chem 55:559-67.
37. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS. (2006). Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355:2631-9.
38. Zairis MN, Tsiaousis GZ, Georgilas AT, Makrygiannis SS, Adamopoulou EN, Handanis SM, Batika PC, Prekates AA, Velissaris D, Kouris NT, Mytas DZ, Babalis DK, Karidis KS, Foussas SG. (2009). Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol Jan 19 [Epub ahead of print].
39. Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlov J. (2008). Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358:2107-16.
40. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M. (2005). Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48-54. (Pubitemid 40066382)